Beth Israel Deaconess (BI Lahey)/Harvard Cancer Center

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early